Torrent Pharmaceuticals Ltd Peer Comparison

Torrent Pharma to Acquire 49.19% Stake in JB Chemicals via ₹19,500 Crore Deal

 Copy Link

The acquisition values JB Chemicals at ₹25,689 crore on a fully diluted basis, according to the company’s official announcement.

Torrent Pharma logs 11% y-o-y growth in Q4 net profit

 Copy Link

On the operating front, EBITDA for the quarter was reported at ₹964 Crore. It was 9.20% higher than ₹883 in Q4FY24.

Top Stocks for Today - 27th January 2025

 Copy Link

Here are some of the stocks that may see significant price movement today: JK Cement, KEC International, Macrotech Developers, etc.

Torrent Pharma announces acquisition of 3 anti-diabetes brands

 Copy Link

Empagliflozin is a new sodium-glucose co-transporter-2 (SGLT-2) inhibitor approved for glycemic management in individuals with type 2 diabetes.

USFDA concludes Torrent Pharma’s inspection with VAI

 Copy Link

The USFDA examined Torrent's manufacturing plant in Pithampur during the September quarter and issued a Form 483 with one observation.

Torrent Pharma promoter to pare 2.9% stake via block deal

 Copy Link

The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.

Torrent Pharma Q2 Profit Soars 17.3%, Revenue Grows 8.6%

 Copy Link

When compared to the previous quarter, revenue growth was modest at 1.05%, while net profits experienced a slight decline of 0.88%.

Torrent Pharma’s Shelcal 500 fails CDSCO quality test

 Copy Link

In August, the CDSCO banned more than 156 fixed-dose combination medications from the Indian market.

Top 10 Stocks for today - 27th September, 2024

 Copy Link

Here are some of the stocks that may see significant price movement today: Nuvama Wealth, RITES, Torrent Pharmaceuticals, etc.

Torrent Pharma logs 20% y-o-y growth in Q1 net profit

 Copy Link

The company announced that its India business grew by 10% year on year in the June quarter, with sales rising to ₹1,635 Crore from ₹1,426 Crore in Q1 FY24.